TrialContemporary clinical trials2016

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.

Christopher Coyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.